Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer

PURPOSE: Erlotinib-gemcitabine combined chemotherapy is considered as the standard treatment for unresectable pancreatic cancer. This study aimed to determine the clinical factors associated with response to this treatment. MATERIALS AND METHODS: This retrospective study included 180 patients with u...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Yonsei Med J
Autors principals: Moon, Do Chang, Lee, Hee Seung, Lee, Yong Il, Chung, Moon Jae, Park, Jeong Youp, Park, Seung Woo, Song, Si Young, Chung, Jae Bock, Bang, Seungmin
Format: Artigo
Idioma:Inglês
Publicat: Yonsei University College of Medicine 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4960377/
https://ncbi.nlm.nih.gov/pubmed/27401642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2016.57.5.1124
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars